Dysmenorrhoea and Prostaglandins

Summary Primary dysmenorrhoea is characterised by painful menstrual cramps which appear to have no macroscopically identifiable pelvic pathology. 50% of postpubescent females suffer from dysmenorrhoea, and 10% are incapacitated for 1 to 3 days each month. Many of these patients have an increased synthesis of prostaglandins in their endometrial tissue with increased prostaglandin release in the menstrual fluid. The increased amount of prostaglandins induces incoordinate hyperactivity of the uterine muscle resulting in uterine ischaemia and pain. Recent clinical and laboratory studies have shown that many of the non-steroidal anti-inflammatory drugs such as ibuprofen, naproxen, flufenamic acid, mefenamic acid and indomethacin are capable of relieving primary dysmenorrhoea. These drugs are inhibitors of the prostaglandin synthetase enzymes which are necessary for prostaglandin biosynthesis. Thus, with ibuprofen it has been shown that clinical relief of the dysmenorrhoeic symptoms accompanies the reduction of menstrual fluid prostaglandins. With the oral contraceptive pill there is good relief of primary dysmenorrhoea, significant decrease in menstrual fluid prostaglandins, but no reduction in menstrual fluid volume; this suggests that the reduction in prostaglandins is secondary to the inhibition of endometrial growth and development. In some forms of secondary dysmenorrhoea elevated prostaglandin levels have been implicated. However, the evidence is less conclusive for dysmenorrhoea secondary to endometriosis and uterine myomas than for dysmenorrhoea associated with intrauterine devices. With the intrauterine device, prostaglandin synthetase inhibitors such as flufenamic acid, ibuprofen and naproxen are able not only to relieve dysmenorrhoea but also to reduce menstrual blood loss to normal levels. Thus, the use of appropriately selected prostaglandin synthetase inhibitors can offer effective relief from the miseries of some types of dysmenorrhoea with subsequent restoration of normal daily activities. Similar content being viewed by others References Anderson, A.B.M.; Gillebaud, J.; Haynes, P.J. and Turnbull, A.C.: Reduction of menstrual blood-loss by prostaglandin synthetase inhibitors. Lancet 1: 774 (1976). Anderson, A.B.M.; Haynes, P.J.; Fraser, I.S. and Turnbull, A.C.: Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea. Lancet 1: 345 (1978). Budoff, P.W.: Use of mefanamic acid in the treatment of primary dysmenorrhea. Journal of the American Medical Association 241: 2713 (1979). Chan, W.Y. and Dawood, M.Y.: Prostaglandin levels in menstrual fluid of non-dysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy; in Samuelsson, Ramwell and Paoletti (Eds) Advances in Prostaglandin Thromboxane Research 8: 1443 (Raven Press, New York 1980). Chan, W.Y.; Dawood, M.Y. and Fuchs, F.: Relief of dysmenorrhea with the prostaglandin synthetase inhibitor ibuprofen: Effect on prostaglandin levels in menstrual fluid. American Journal of Obstetrics and Gynecology 135(1): 102 (1979). Chan, W.Y. Dawood, M.Y. and Fuchs, F.: Prostaglandin in primary dysmenorrhea. Comparison of prophylactic and non-prophylactic treatment with ibuprofen and use of oral contraceptives. American Journal of Medicine 70: 535 (1981). Corson, S.L. and Bolognese, R.J.: Ibuprofen therapy for dysmenorrhea. Journal of Reproductive Medicine 20: 246 (1978). Dandenell, L.-O.; Lalos, O.; Lisciak, J.; Sandström, B.; Barany, S. and Nilsson, B.: Clinical experience of naproxen in the treatment of primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica (Suppl.) 87: 95 (1979). Davies, A.J.; Anderson, A.B.M. and Turnbull, A.C.: Reduction by naproxen of excessive menstrual bleeding in women using an intrauterine device. Obstetrics and Gynecology 57: 74 (1981). Downie, J.; Poyser, N.L.; and Wunderlich, M.: Levels of prostaglandins in human endometrium during the normal menstrual cycle. Journal of Physiology 236: 465 (1974). Hamann, G.O.: Severe primary dysmenorrhea treated with naproxen. A prospective, double-blind, cross-over investigation. Prostaglandins 19: 651 (1980). Hamann, G.O. and Laursen, B.: Primaer Dysmenoré behandlet med indometacin. Ugeskrift Laegerske 139: 1899 (1977). Henzl, M.R. and Izu, A.: Naproxen and naproxen sodium in dysmenorrhea: Development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy. Acta Obstetricia et Gynecologica Scandinavica (Suppl.) 87: 105 (1979). Henzl, M.R.; Buttram, V.; Segre, E.J.; Bessler, S.: The treatment of dysmenorrhea with naproxen sodium. A report on two independent double-blind trials. American Journal of Obstetrics and Gynecology 127: 818 (1977). Jacobson, J.; Cavalli-Björkman, K.; Lundström, V.; Nilsson, B. and Norbeck, M.: Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience. Acta Obstetricia Gynecologica Scandinavica (Suppl.) 87: 73 (1979). Janbu, T.; Løkken, P. and Nesheim, B.-I.: Effect of acetylsalicylic acid, paracetamol and placebo on pain and blood loss in dysmenorrheic women. Acta Obstetricia et Gynecologica Scandinavica (Suppl.) 87: 81 (1979). Kajanoja, P. and Vesanto, T.: Naproxen and indomethacin in the treatment of primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica (Suppl.) 87: 87 (1979). Kapadia, L. and Elder, M.G.: Flufenamic acid in treatment of primary spasmodic dysmenorrhea. A double-blind cross-over study. Lancet 1: 348 (1978). Kauppila, A. and Ylikorkala, O.: Indomethacin and tolfenamic acid in primary dysmenorrhoea. European Journal of Obstetrics, Gynaecology and Reproductive Biology 7: 59 (1977). Kauppila, A.; Poulakka, J. and Ylikorkala, O.: The relief of primary dysmenorrhea by ketoprofen and indomethacin. Prostaglandins 18: 647 (1979). Klein, J.R. and Litt, I.E.: Trial of a prostaglandin synthetase inhibitor: Acetylsalicylate on a population of severely dysmenorrheic adolescents. A double-blind, cross-over study. Presented at the Society of Pediatric Research, San Antonio, Texas (May 1980). Larkin, R.M.; Van Orden, D.E.; Poulson, A.M. and Scott, J.R.: Dysmenorrhea: Treatment with an antiprostaglandin. Obstetrics and Gynecology 54: 456 (1979). Layes Molla, A. and Donald, J.F.: A comparative study of ibuprofen and paracetamol in primary dysmenorrhea. Journal of International Medical Research 2: 395 (1974). Lundström, V.: Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors — a promising therapeutic alternative. Acta Obstetricia et Gynecologica Scandinavica 57: 421 (1978). Lundström, V. and Green, K.: Endogenous levels of prostaglandin and its main metabolites in plasma and endometrium of normal and dysmenorrheic women. American Journal of Obstetrics and Gynecology 130: 640 (1978). Roy, S.: Personal Communication (1980). Singh, E.J.; Baccarini, I.M. and Zuspan, F.P.: Levels of prostaglandins F2α and E2 in human endometrium during the menstrual cycle. American Journal of Obstetrics and Gynecology 121: 1003 (1975). William, E.A.; Collins, W.P. and Clayton, S.G.: Studies in the involvement of prostaglandins in uterine symptomatology and pathology. British Journal of Obstetrics and Gynaecology 83: 337 (1976). Ylikorkala, O. and Dawood, M.Y.: New concepts in dysmenorrhea. American Journal of Obstetrics and Gynecology 130: 833 (1978) Author information Authors and Affiliations Rights and permissions About this article Cite this article Dawood, M.Y. Dysmenorrhoea and Prostaglandins: Pharmacological and Therapeutic Considerations. Drugs 22, 42–56 (1981). https://doi.org/10.2165/00003495-198122010-00003 Published: Issue date: DOI: https://doi.org/10.2165/00003495-198122010-00003